[HTML][HTML] Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer
W Wang, F Li, P Gan, B Li, S Li - Frontiers in Surgery, 2022 - frontiersin.org
Objective Liver cancer is a significant contributor to global burden of cancer. Transcatheter
arterial chemoembolization (TACE) is the standard of care for patients with unresectable …
arterial chemoembolization (TACE) is the standard of care for patients with unresectable …
[HTML][HTML] CalliSpheres® microspheres drug-eluting bead transhepatic artery chemoembolization with or without sorafenib for the treatment of large liver cancer: a multi …
S Liu, G Yu, Q Wang, L Li, Y Liu, K Du… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Purpose: To explore the clinical efficacy and safety of CalliSpheres® microspheres drug-
eluting bead transarterial chemoembolization (DEB-TACE) combined with sorafenib in the …
eluting bead transarterial chemoembolization (DEB-TACE) combined with sorafenib in the …
[HTML][HTML] CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety …
B Wu, J Zhou, G Ling, D Zhu, Q Long - World journal of surgical oncology, 2018 - Springer
Background The present study aimed to evaluate the short-term efficacy and safety of drug-
eluting beads transarterial chemoembolization (DEB-TACE) with CalliSpheres Beads …
eluting beads transarterial chemoembolization (DEB-TACE) with CalliSpheres Beads …
Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer
J Zhang, G Feng, Y Li, W Wang - Asia‐Pacific Journal of …, 2022 - Wiley Online Library
Purpose The optimal microparticle size for drug‐eluting beads transarterial
chemoembolization (DEB‐TACE) remains unknown. This retrospective cohort study …
chemoembolization (DEB‐TACE) remains unknown. This retrospective cohort study …
[HTML][HTML] Oxaliplatin eluting CalliSpheres microspheres for the treatment of unresectable or recurrent hepatocellular carcinoma
Y Bi, K Ren, J Ren, J Ma, X Han - Frontiers in Pharmacology, 2022 - frontiersin.org
Aim: Drug-eluting beads-transarterial chemoembolization (DEB-TACE) has been widely
used in unresectable and advanced hepatocellular carcinoma (HCC). However, no study …
used in unresectable and advanced hepatocellular carcinoma (HCC). However, no study …
Efficacy and safety of raltitrexed-eluting CalliSpheres® bead transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma: a single …
Z Sun, D Jiao, Y Fang, Y Liu, K Xu… - Therapeutic …, 2024 - journals.sagepub.com
Background: The most common loadable chemotherapeutic drugs in drug-eluting bead
transarterial chemoembolization (DEB-TACE) include doxorubicin, epirubicin, etc …
transarterial chemoembolization (DEB-TACE) include doxorubicin, epirubicin, etc …
Research progress on transcatheter arterial chemoembolization with drug-eluting bead for liver malignant tumors
W Yu-Feng, HE Dong-Feng - Jie Fang Jun Yi Xue Za Zhi, 2022 - search.proquest.com
Liver cancer is a common malignant tumor of digestive system, including primary liver
cancer and secondary liver cancer. Primary liver cancer can be divided mainly into …
cancer and secondary liver cancer. Primary liver cancer can be divided mainly into …
[HTML][HTML] Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients
N Peng, L Mao, Y Tao, K Xiao, G Yuan, S He - World Journal of Surgical …, 2022 - Springer
Purpose The purpose was to explore the effect of drug-eluting beads transarterial
chemoembolization (DEB-TACE) on down-staging in unresectable liver cancer patients …
chemoembolization (DEB-TACE) on down-staging in unresectable liver cancer patients …
[HTML][HTML] Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma
C Wang, J Xia, Z Yang, W Zhou, W Chen, C Qi, J Gu… - Scientific reports, 2020 - nature.com
The study aimed to compare the tumor response to and complications of doxorubicin-eluting
CalliSphere bead-transarterial chemoembolization (DEB-TACE) using small-and medium …
CalliSphere bead-transarterial chemoembolization (DEB-TACE) using small-and medium …
[HTML][HTML] The comprehensive analysis of efficacy and safety of CalliSpheres® drug-eluting beads transarterial chemoembolization in 367 liver cancer patients: A …
Z Peng, G Cao, Q Hou, L Li, S Ying, J Sun… - Oncology …, 2020 - ncbi.nlm.nih.gov
This study aimed to investigate the efficacy, safety, and prognostic factors of drug-eluting
beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver …
beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver …